Both in Pharmaceuticals
TherapeuticsMD vs Edesa Biotech
Over the past year TXMD returned +54.8% and EDSA returned +31.0%; their daily moves had a correlation of 0.00.
TXMD +54.8% EDSA +31.0%Growth of $1, one year, split-adjusted
| Metric | TXMD | EDSA |
|---|---|---|
| Price | $1.78 | $2.28 |
| Market cap | $20.6M | $22.0M |
| Today | −1.66% | −6.56% |
| 1 month | −11.4% | −41.7% |
| 6 months | −14.0% | −85.2% |
| Year to date | +9.2% | +60.6% |
| 1 year | +49.6% | +22.6% |
| Revenue growth (YoY) | −8.7% | — |
| Gross margin | 100.0% | — |
| Net margin | 17.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.3× | — |
| Net cash | $9.2M | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 33.8% | 89.5% |
| Short % of float | 0.2% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).